United States Pharmacopeial Convention. Compounding Compendium. Rockville, MD: United States Pharmacopeia; 2020.

United States Pharmacopeial Convention. Compounding Compendium. Rockville, MD: United States Pharmacopeia; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <795> pharmaceutical compounding—nonsterile preparations. USP 43−NF 38; 2020.

United States Pharmacopeial Convention. General chapter <795> pharmaceutical compounding—nonsterile preparations. USP 43−NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <797> pharmaceutical compounding—sterile preparations. USP 43−NF 38; 2020.

United States Pharmacopeial Convention. General chapter <797> pharmaceutical compounding—sterile preparations. USP 43−NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <800> hazardous drugs—handling in healthcare settings. USP 43−NF 38; 2020.

United States Pharmacopeial Convention. General chapter <800> hazardous drugs—handling in healthcare settings. USP 43−NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <795> pharmaceutical compounding—nonsterile preparations. USP 42−NF 37, second supplement; 2019.

United States Pharmacopeial Convention. General chapter <795> pharmaceutical compounding—nonsterile preparations. USP 42−NF 37, second supplement; 2019.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <1178> good repackaging practices. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <1178> good repackaging practices. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Food and Drug Administration. Repackaging of certain human drug products by pharmacies and outsourcing facilities, 2017. https://www.fda.gov/downloads/Drugs/Guidances/UCM434174.pdf. Accessed May 17, 2020.

United States Food and Drug Administration. Repackaging of certain human drug products by pharmacies and outsourcing facilities, 2017. https://www.fda.gov/downloads/Drugs/Guidances/UCM434174.pdf. Accessed May 17, 2020.)| false
• Search Google Scholar
• Export Citation

Kienle PC. The Chapter <800> Answer Book. Bethesda, MD: ASHP; 2017.

Kienle PC. The Chapter <800> Answer Book. Bethesda, MD: ASHP; 2017.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <825> radiopharmaceuticals—preparation, compounding, dispensing, and repackaging. USP 43−NF 38; 2020.

United States Pharmacopeial Convention. General chapter <825> radiopharmaceuticals—preparation, compounding, dispensing, and repackaging. USP 43−NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <1168> compounding for phase 1 investigational studies. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <1168> compounding for phase 1 investigational studies. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

NIOSH List of antineoplastic and other hazardous drugs in healthcare settings, 2016. Publication number 2016-161. https://www.cdc.gov/niosh/docs/2016-161/pdfs/2016-161.pdf?id=10.26616/NIOSHPUB2016161. Accessed May 17, 2020.

NIOSH List of antineoplastic and other hazardous drugs in healthcare settings, 2016. Publication number 2016-161. https://www.cdc.gov/niosh/docs/2016-161/pdfs/2016-161.pdf?id=10.26616/NIOSHPUB2016161. Accessed May 17, 2020.)| false
• Search Google Scholar
• Export Citation

United States Food and Drug Administration. Compounded drug products that are essentially copies of a commercially available drug product under section 503a of the federal Food, Drug, and Cosmetic Act guidance for industry. 2018. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM510154.pdf. Accessed May 17, 2020.

United States Food and Drug Administration. Compounded drug products that are essentially copies of a commercially available drug product under section 503a of the federal Food, Drug, and Cosmetic Act guidance for industry. 2018. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM510154.pdf. Accessed May 17, 2020.)| false
• Search Google Scholar
• Export Citation

ASHP Sterile Products Preparation Certificate Program, 2019. www.ashp.org. Accessed Accessed May 17, 2020.

ASHP Sterile Products Preparation Certificate Program, 2019. www.ashp.org. Accessed Accessed May 17, 2020.)| false
• Search Google Scholar
• Export Citation

CriticalPoint, LLC. www.criticalpoint.info. Accessed May 17, 2020.

Board of Pharmacy Specialties. BPS Board Certified Sterile Compounding Pharmacist (BCSCP). www.bpsweb.org. Accessed May 17, 2020.

Pharmacy Technician Certification Board. Certified Compounded Sterile Preparation Technician Program. https://www.ptcb.org/about-ptcb/news-room/whats-new-at-ptcb/2017/12/06/ptcb-launches-certified-compounded-sterile-preparation-technician-(cspt-)-program. Accessed May 17, 2020.

Murdaugh LB. Competence Assessment Tools for Health-System Pharmacies. 5th ed. Bethesda, MD: ASHP; 2015.

Murdaugh LB. Competence Assessment Tools for Health-System Pharmacies. 5th ed. Bethesda, MD: ASHP; 2015.)| false
• Search Google Scholar
• Export Citation

Hennenfent JA, Pace HA, eds. Pharmacy Competency Assessment Center. Bethesda, MD: ASHP; 2019.

Hennenfent JA, Pace HA, eds. Pharmacy Competency Assessment Center. Bethesda, MD: ASHP; 2019.)| false
• Search Google Scholar
• Export Citation

United States Department of Labor. Occupational Safety and Health Administration. HAZCOM 1994 program guidance. https://www.osha.gov/dsg/hazcom/solutions.html. Accessed May 17, 2020.

United States Department of Labor. Occupational Safety and Health Administration. Hazard communication. https://www.osha.gov/dsg/hazcom/HCSFinalRegTxt.html. Accessed May 17, 2020.

United States Department of Labor. Occupational Safety and Health Administration. Hazard communication: Small entity compliance guide for employers that use hazardous chemicals. https://www.osha.gov/Publications/OSHA3695.pdf. Accessed May 17, 2020.

Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, The National Personal Protective Technology Laboratory. Respirator Trusted-Source Information. List of approved filtering facepiece respirators. http://www.cdc.gov/niosh/npptl/topics/respirators/disp_part/respsource.html. Accessed May 17, 2020.

Centers for Disease Control and Prevention, hand hygiene in healthcare settings. www.cdc.gov/handhygiene. Accessed May 17, 2020.

United States Food and Drug Administration. FD&C Act provisions that apply to human drug compounding. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm606955.htm. Accessed May 17, 2020.

United States Pharmacopeial Convention. General chapter <1231> water for pharmaceutical purposes. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <1231> water for pharmaceutical purposes. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <41> balances. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <41> balances. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <1176> prescription balances and volumetric apparatus used in compounding. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <1176> prescription balances and volumetric apparatus used in compounding. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <1251> weighing on an analytical balance. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <1251> weighing on an analytical balance. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Food and Drug Administration. Bulk drug substances used in compounding under section 503a of the FD&C Act. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm614204.htm. Accessed May 17, 2020.

ASHP. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. Am J Hosp Pharm. 1994;51:1441-1448.

ASHP. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. Am J Hosp Pharm. 1994;51:1441-1448.)| false
• Search Google Scholar
• Export Citation

International Journal of Pharmaceutical Compounding. www.ijpc.org. Accessed May 17, 2020.

Allen LV, Bassani GS, Edmund J, et al. Strength and stability testing for compounded preparations. United States Pharmacopeial Convention. https://www.usp.org/sites/default/files/usp/document/FAQs/strength-stability-testing-compounded-preparations.pdf. Accessed May 17, 2020.

United States Pharmacopeial Convention. General chapter <51> antimicrobial effectiveness testing. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <51> antimicrobial effectiveness testing. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <659> packaging and storage requirements. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <659> packaging and storage requirements. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <1112> application of water activity determination for nonsterile pharmaceutical products. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <1112> application of water activity determination for nonsterile pharmaceutical products. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation

Power LA, Coyne JW. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2018;75:1996-2031.

Power LA, Coyne JW. ASHP guidelines on handling hazardous drugs. Am J Health-Syst Pharm. 2018;75:1996-2031.)| false
• Search Google Scholar
• Export Citation

United States Pharmacopeial Convention. General chapter <1163> quality assurance in pharmaceutical compounding. USP 43–NF 38; 2020.

United States Pharmacopeial Convention. General chapter <1163> quality assurance in pharmaceutical compounding. USP 43–NF 38; 2020.)| false
• Search Google Scholar
• Export Citation